67 search results for: pediatric

Christos Tzivinikos
Expert
Christos Tzivinikos, MD

Christos Tzivinikos, MD, is a consultant pediatric gastroenterologist and founder of the Gastroenterology Department at Al Jalila Children’s Specialty Hospital in Dubai, United Arab Emirates

Antonella Cianferoni
Expert
Antonella Cianferoni, MD, PhD

Associate Professor in Pediatrics | Perelman School of Medicine, University of Pennsylvania; Medical Director of the Food Allergy Immunotherapy Program | Children’s Hospital of Philadelphia, Pennsylvania, United States

EAACI PAAM 2025 | How Type 2 Inflammation Shapes a Lifetime
Type 2 Inflammation
EAACI PAAM 2025 | How Type 2 Inflammation Shapes a Lifetime
expert video

Join ADVENT faculty members Len Bacharier, Antonella Cianferoni, and Andre Moreira for an educational symposium highlighting type 2 inflammation and its shared and distinct roles in multiple chronic pediatric diseases.

View more
Lawrence F. Eichenfield
Expert
Lawrence F. Eichenfield, MD

Vice Chair of the Department of Dermatology | University of California San Diego (UCSD) School of Medicine; Chief of Pediatric and Adolescent Dermatology | Rady Children’s Hospital San Diego, California, United States

Peter Lio
Expert
Peter Lio, MD

Clinical Professor of Dermatology at the Icahn School of Medicine at Mount Sinai, NY; Clinical Assistant Professor of Dermatology & Pediatrics at Northwestern University Feinberg School of Medicine, Chicago, Illinois, US

Seema Aceves
Expert
Seema Aceves, MD, PhD

Professor of Pediatrics and Medicine in the Division of Allergy and Immunology | University of California, San Diego; Director of the Eosinophilic Gastrointestinal Disorders Clinic | Rady Children’s Hospital–San Diego, California, United States

Beyond Clinical Control: Targeting Type 2 Inflammation for Improved Patient Outcomes
Dermatology
Beyond Clinical Control: Targeting Type 2 Inflammation for Improved Patient Outcomes
expert video

Prof Alan Irvine presents the latest clinical and real-world evidence supporting the potential for disease modification in atopic dermatitis, at EADV 2025.

View more
2025 ADVENT Forum | Joint Plenary Session: A View into the Life of Our Patients Video
Type 2 Inflammation
2025 ADVENT Forum | Joint Plenary Session: A View into the Life of Our Patients Video
expert video

This cross-TA plenary session addressed challenges in type 2 inflammation-driven diseases. Esteemed faculty, including Profs Klaus Rabe, Sharon Dell, Anju Peters, Milli Gupta, Eric Simpson, Stella Lee, and moderator Oscar Palomares, discussed strategies to enhance quality of life, reduce disease burden, and prioritize patient-centered care.

View more
Can Therapy-Free Disease Control Be Achieved in Atopic Dermatitis?
Dermatology
Can Therapy-Free Disease Control Be Achieved in Atopic Dermatitis?
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Prof. Amy Paller reviews a Japanese study showing that early proactive treatment of infant atopic dermatitis with topical corticosteroids reduced the incidence of food allergy but was also associated with decreased gains in height and weight.

View more
EADV 2025
On Demand
The Burden of a Lifetime: Can Disease Modification Rewrite the Narrative of Atopic Dermatitis?

Join Professors Jean-David Bouaziz, Amy Paller, and Alan Irvine for a dynamic presentation on the multifaceted burden of atopic dermatitis, the evolving concept of disease modification, and how targeted systemic therapies may help improve long-term patient outcomes.

The Burden of a Lifetime: Can Disease Modification Rewrite the Narrative of Atopic Dermatitis?
Dermatology
The Burden of a Lifetime: Can Disease Modification Rewrite the Narrative of Atopic Dermatitis?
expert video

Professors Bouaziz, Paller, and Irvine discuss the clinical burden of atopic dermatitis, the biomarkers of subclinical control, and evidence of potential disease modification in AD at EADV 2025.

View more
Navigating Complex Definitions: Early Intervention and Disease Modification in Atopic Dermatitis
Dermatology
Navigating Complex Definitions: Early Intervention and Disease Modification in Atopic Dermatitis
expert video

Dr. Amy Paller discusses the evolving concepts of early intervention and disease modification in AD and describes potential biomarkers of subclinical control at EADV 2025.

View more